Quantcast

Latest Nephrology Stories

2014-05-21 08:29:46

BOULDER, Colo., May 21, 2014 /PRNewswire/ -- People are individuals. They differ. Patients differ too. Yet, patients with chronic diseases are frequently treated using protocols that ignore patient variability and that have rarely been tested in diverse populations. They do not take into account characteristics that may influence responses to treatment such as age, race, gender, and co-morbid illnesses. Continuous Quality Improvement (CQI) is an iterative, continuing, process used in...

2014-05-20 23:15:53

Vida Communication’s highly successful Hispanic public relations campaign for the NephCure Foundation, fully leveraging the support of a prominent Latino boxer, is prominently included in the current edition of PR Week magazine’s “Campaign Case Studies” section. New York, NY (PRWEB) May 20, 2014 VIDA Communications, a New York City based boutique multicultural public relations agency dedicated to helping brands connect and engage with the growing U.S. Hispanic community, is...

2014-05-20 16:26:27

Dialyspa, the state-of-the-art dialysis centers whose mission is changing the dialysis experience, has just received the Gold Seal of Approval(TM) HOUSTON, May 20, 2014 /PRNewswire/ -- Dialyspa, the Houston-based state-of-the-art dialysis centers with unparalleled commitment to patient comfort and satisfaction, has just received the Gold Seal of Approval(TM) by The Joint Commission. Dialyspa is now part of the elite few dialysis companies to have received this prestigious...

2014-05-20 08:33:24

SAN DIEGO, May 20, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQX:AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that it has entered into a definitive agreement with DaVita Clinical Research( )(DCR) to provide clinical management services to support the forthcoming feasibility study of the Aethlon Hemopurifier®. The Hemopurifier is a first-in-class therapeutic...

2014-05-19 16:24:33

RIVER EDGE, N.J., May 19, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today the appointment of Matthew S. Rosenberg, M.D., to its Board of Directors. Dr. Rosenberg is an accomplished professional with extensive healthcare public policy experience. Dr....

2014-05-19 08:28:07

LAWRENCE, Mass., May 19, 2014 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, is proud to share a current NxStage® System One(TM) user's story of courage, persistence and determination. Despite losing both of his kidneys to cancer, Greg, a 65-year-old avid runner, was able to accomplish his goal of running a half marathon this past February in Sacramento. For Greg, more frequent home hemodialysis (HHD) with the NxStage...

2014-05-15 23:08:44

ChinaMarketResearchReports.com adds "Global and China Hemodialysis Industry Report, 2013-2016" market research, on hemodialysis service market and hemodialysis equipment market, to its store. Dallas, TX (PRWEB) May 15, 2014 Global and China Hemodialysis Industry Report, 2013-2016 market research says in 2013, the global number of patients receiving dialysis continued to grow to 2.519 million. The new patients mainly come from Asia Pacific region (excluding Japan). Europe,...

2014-05-15 08:32:20

Study will evaluate tenapanor for the treatment of hyperphosphatemia in ESRD patients on hemodialysis FREMONT, Calif., May 15, 2014 /PRNewswire/ -- Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, GI and metabolic diseases, today announced that it has received a $25 million milestone payment from AstraZeneca (NYSE:AZN, LON:AZN) for the initiation of a Phase 2b clinical trial evaluating tenapanor for the treatment of hyperphosphatemia, or elevated...

2014-05-14 16:28:26

RIVER EDGE, N.J., May 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today that John C. Houghton, President and Chief Executive Officer, will present at the Third Annual Marcum MicroCap Conference in New York on Thursday, May 29, 2014 at 3:30 p.m. EDT....

2014-05-14 16:28:23

RIVER EDGE, N.J., May 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months ended March 31, 2014. Recent Highlights -- Commenced shipment of our NanoGuard-D and NanoGuard-S ultrafilters -- Extended and...


Latest Nephrology Reference Libraries

Hypertension (journal)
2012-05-14 11:48:30

Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...

More Articles (1 articles) »
Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related